We Hear You. Cost of Living and Weight Loss Injections: The Honest Conversation No One Else Is Having

This blog is a little different. It is not going to lead with trial data or clinical comparisons. It is going to start where most people actually start: with the very real and very difficult question of whether weight loss injections like Mounjaro or Wegovy are something they can actually afford — right now, in 2026, in a country where almost half of all households say their finances have worsened over the past year.

At Happy Pharmacy, we hear this every week. From patients who want to start treatment but feel it is out of reach. From people already on treatment who are worried about how long they can sustain the cost. And from people who feel guilty even considering a private prescription when the household budget is already stretched. We want to address all of that — honestly, directly, and without any pressure.

The Financial Reality of Life in the UK Right Now

Let us be direct about the backdrop. The UK cost of living crisis that began in earnest in 2021 has not gone away. Prices may not be rising at the dramatic rates seen at the peak, but they have not fallen back either. Cumulative food prices remain around 20 to 25% above their pre-crisis levels. Household energy bills, whilst subject to some targeted government support from April 2026, are still significantly higher than most families were paying three years ago. Rent is rising in most regions, and millions of mortgage holders still face higher monthly repayments as fixed-rate deals expire.

The numbers from trusted national surveys paint a stark picture. A YouGov poll conducted at the start of 2026 found that 49% of Britons said their household finances had worsened in the previous twelve months. Some 44% said they had struggled to pay for food in the past three months. Just 12% expected things to improve this year. The Financial Conduct Authority, meanwhile, found that 24% of adults were finding it difficult to cope financially as recently as mid-2024.

Sources: YouGov UK Cost of Living Survey, January 2026; Financial Conduct Authority Financial Lives Survey 2024; ONS Household Cost Indices; House of Commons Library, CBP-10100, updated April 2026.

The House of Commons Library has also documented that the proportion of people in food-insecure households rose from 7% in 2021/22 to 11% in 2022/23 — and that figure has not recovered. For context, UK households spent an average of 11% of all their expenditure on food and non-alcoholic drink in 2023/24, according to ONS data. When that category inflates by nearly 20%, the pressure on everything else compounds rapidly.

Against this backdrop, asking people to spend £100 to £300 a month on a private weight loss prescription is a significant ask. We realise that.

The Part Nobody Talks About: What You Might Save

Here is where the conversation gets more interesting — and more honest. Weight loss injections like Mounjaro and Wegovy work by reducing appetite, slowing gastric emptying, and making the body feel full with far less food. This does not just produce weight loss results. It changes spending habits in ways that patients often do not fully anticipate when they are comparing the cost of treatment to their current budget.

A major study published in the Journal of Marketing Research in December 2025, led by researchers at Cornell University, found that household grocery spending dropped by more than 5% within six months of a family member starting on a GLP-1 medication like semaglutide or tirzepatide. For households with higher food spending, the reduction was even more pronounced — exceeding 8%. Spending on calorie-dense processed foods showed the steepest falls, with purchases of crisps and savoury snacks down around 10%, sweet bakery items down nearly 9%, and fast food and coffee shop visits declining by approximately 8%.

Analysis has also noted that alcohol consumption is also falling meaningfully among GLP-1 users, with many switching to lower-calorie alternatives or reducing intake substantially. This is a spending category that represents a significant monthly outgoing for many households — and one where the savings can be tangible.

We have built a free-to-use Food Cost Saving Calculator on our website, which allows patients to estimate the personal food and drink savings they might realistically expect to see based on their current spending patterns. It is not a guarantee — every patient's experience is different — but it provides a useful, honest framework for thinking about the true net cost of treatment.

Try the Happy Pharmacy Food Cost Saving Calculator to see what your net monthly cost could realistically look like.

Sources: Cornell University / Journal of Marketing Research, December 2025; Treated.com GLP-1 Consumer Behaviour Analysis, March 2026; BBC News, Five Ways Weight-Loss Jabs Are Changing Spending Habits, 2026; Novo Nordisk parliamentary evidence submission, August 2025.  *US dollar figure converted to approximate GBP equivalent for illustrative purposes.

Putting the Numbers Together

No provider should promise that weight loss injections will pay for themselves — that would be misleading. But understanding the full financial picture, rather than just the prescription cost in isolation, genuinely matters when you are making a difficult budget decision. Here is a simplified view of the monthly cost versus the realistic offsets many patients experience:

Indicative figures only. Individual savings will vary based on current food and alcohol spending, household size, and treatment dose. Please use the Happy Pharmacy Food Cost Saving Calculator for a personalised estimate.

For a patient on the standard Wegovy 2.4mg dose at around £90 per month, realistic combined food, alcohol, and discretionary spending reductions of £60 to £90 per month bring the effective net cost closer to £30 per month for many people. That is not trivial, but it is a meaningfully different number to the one that appears on the prescription page.

Beyond immediate spending, the longer-term health picture is also relevant. NICE has concluded that Mounjaro and Wegovy are cost-effective treatments for obesity in the UK — in part because the conditions associated with obesity (type 2 diabetes, cardiovascular disease, hypertension, musculoskeletal problems) carry very significant long-term costs to both individuals and the health system. Evidence presented to parliament by Novo Nordisk in August 2025 noted that weight loss of 10 to 25% has been associated with lower healthcare use, including fewer prescriptions and GP visits. These are not immediate savings, but they are real ones over time.

Happy Pharmacy's Commitment to You: Transparent, Fair, and Honest

We want to be very clear about where Happy Pharmacy stands on pricing, because we think transparency matters — especially now.

Happy Pharmacy is a GPhC-registered online pharmacy with a TrustPilot rating of 4.8 out of 5 — a score built on real patient feedback, not marketing claims. We provide regulated, personal access to both Mounjaro and Wegovy through thorough clinical consultations with registered prescribers. We do not cut corners on safety or service, and we never will. But we also understand that pricing is a genuine concern for the patients we serve, and we think honesty about that is part of good patient care.

We are also conscious that the cost landscape has shifted with Eli Lilly's September 2025 price increase on Mounjaro — an increase of up to 170% at the highest maintenance doses for private patients, as reported by the BBC. We will not pretend that this has not made the conversation harder. What we can promise is that we will always offer clear, straightforward pricing, never add unexpected charges, and always prioritise the right clinical outcome over upselling to a higher dose than a patient needs.

Safety First — Always

It is worth saying this plainly: the reason Happy Pharmacy will not compromise on clinical rigour, even in a cost-of-living crisis, is because your safety is non-negotiable. The MHRA updated its guidance in January 2026, reminding patients and prescribers to be alert to the small but real risk of serious side effects associated with GLP-1 medications, including acute pancreatitis. Weight loss injections are genuinely effective and, for most patients, safe medicines — but they are also powerful prescription treatments that require proper clinical oversight.

The alternative to a regulated online pharmacy like Happy Pharmacy is not free treatment. It is unregulated treatment — from social media sellers, unverified websites, and grey-market suppliers whose products may be counterfeit, incorrectly dosed, or simply dangerous. Border Force seized over 18,300 illegal weight loss and diabetes products between February 2024 and May 2025. The MHRA seized nearly 20 million doses with a street value of around £45 million across 2025 alone. The financial saving from going unregulated is not worth the risk.

If you are weighing up whether weight loss injections are affordable for you right now, we would encourage you to start with our Food Cost Saving Calculator — and then take a free, no-obligation clinical online consultation. There is no pressure to proceed, no hard sell, and no compromises on honesty. Just a personal conversation about what is right for you.

Blog medically reviewed by : Palvinder Deol, GPhC Registered Pharmacist, 8 May 2026

1. YouGov (2026). Britons and the cost of living, January 2026. YouGov.com. 

2. House of Commons Library (2026). High cost of living: Impact on households. CBP-10100. commonslibrary.parliament.uk

3. Financial Conduct Authority (2024). Financial Lives Survey. fca.org.uk

4. MHRA (2026). MHRA updates guidance for GLP-1 prescribers and patients. gov.uk

5. NICE (2024). TA1026: Tirzepatide (Mounjaro) for managing obesity and overweight. nice.org.uk.